RedHill Biopharma (RDHL) Amortization - Intangibles (2014 - 2015)
RedHill Biopharma (RDHL) reported Amortization - Intangibles of $6.6 million for Q4 2015, up 23.12% year-over-year from $5.3 million in Q4 2014, and up 23.12% quarter-over-quarter from $5.3 million in Q4 2014.
RedHill Biopharma (RDHL) Amortization - Intangibles (2014 - 2015) Analysis & Trends
RedHill Biopharma (RDHL) has 2 years of Amortization - Intangibles data on file, last reported at $6.6 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | RedHill Biopharma | 119.32 Mn | 119.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 6.56 Mn |
| Dec 31, 2014 | 5.33 Mn |